Management of Irregular Menstrual Cycles in Patients Taking Lithium
First, evaluate and treat lithium-induced thyroid dysfunction, as this is the most common and well-established cause of menstrual irregularities in lithium-treated patients, then assess for other endocrine abnormalities including hyperprolactinemia.
Primary Evaluation: Thyroid Function
Lithium commonly induces thyroid dysfunction, which directly causes menstrual irregularities 1. The evaluation must include:
- TSH, free T4, and thyroid antibodies - Lithium causes goiter and hypothyroidism in a significant proportion of patients 1
- Thyroid monitoring should be periodic and ongoing throughout lithium therapy 1
- If hypothyroidism is confirmed, treat with levothyroxine to restore euthyroid state, which will typically resolve menstrual irregularities
Important caveat: Patients with normal thyroid tests but hypothyroid symptoms do NOT benefit from thyroid hormone treatment and face substantial risk (approximately 20%) of developing iatrogenic hyperthyroidism 1.
Secondary Evaluation: Prolactin Assessment
Recent evidence suggests lithium may cause hyperprolactinemia leading to amenorrhea 2. This represents an emerging recognition of lithium's endocrine effects:
- Check serum prolactin levels - A 2024 case report documented the first instance of lithium-induced amenorrhea through elevated prolactin 2
- This mechanism differs from antipsychotic-induced hyperprolactinemia and can occur with lithium monotherapy 2
- If prolactin is elevated and other causes excluded, consider whether lithium continuation is essential versus switching to alternative mood stabilizers
Comprehensive Menstrual Dysfunction Assessment
The evaluation should systematically rule out 3:
- Pregnancy (beta-hCG)
- Thyroid disease (TSH) - most likely in lithium patients
- Hyperprolactinemia (prolactin level)
- Structural pathology (transvaginal ultrasound, saline infusion sonohysterography, or hysteroscopy as indicated)
- Endometrial pathology (endometrial biopsy if indicated by age >45 years, risk factors, or abnormal bleeding patterns)
Understanding Lithium-Menstrual Cycle Interactions
The relationship between lithium and menstrual cycles is bidirectional:
- Lithium levels may fluctuate with menstrual phases - Some studies show decreased lithium levels during the luteal phase in bipolar women with premenstrual mood exacerbation 4, though this is not universal 5
- Recent meta-analysis data suggest these pharmacokinetic changes are not clinically significant in most patients 6
- Menstrual dysfunction is common in bipolar disorder itself - One study found menstrual disturbances in all 10 lithium monotherapy patients, but also in patients on other medications, suggesting the underlying psychiatric condition may contribute 7
Treatment Algorithm
If thyroid dysfunction is present:
- Initiate levothyroxine replacement
- Target TSH normalization
- Monitor menstrual cycle restoration over 2-3 months
If hyperprolactinemia is confirmed:
- Assess whether lithium is essential for mood stability
- Consider switching to alternative mood stabilizers if clinically appropriate
- If lithium must be continued, consider dopamine agonist therapy in consultation with endocrinology
If ovulatory dysfunction without identifiable endocrine cause:
- Medical management per ACOG guidelines 3:
- Combined hormonal contraception (first-line if no contraindications)
- Progestin-only contraception (alternative option)
- These treatments address the bleeding pattern while maintaining lithium therapy
If medical treatment fails or is contraindicated:
- Surgical options include endometrial ablation or hysterectomy 3
Critical Monitoring Considerations
- Lithium requires ongoing renal function monitoring due to risk of nephrogenic diabetes insipidus and chronic kidney disease 8
- Maintain therapeutic lithium levels carefully, as toxic levels are close to therapeutic range 8
- Any changes in fluid status, renal function, or concomitant medications (especially diuretics) can precipitate lithium toxicity 8
The evidence strongly supports that thyroid dysfunction is the primary lithium-related cause of menstrual irregularities and should be the first target of evaluation and treatment, with emerging recognition of hyperprolactinemia as an additional mechanism requiring clinical awareness.